Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Genesis Healthcare Inc GENN

Healthcare Medical Care
Genesis Healthcare, Inc. is a holding company. The Company provides services to skilled nursing facilities and assisted/senior living communities. It also specializes in contract rehabilitation therapy, respiratory therapy, physician services, staffing services, and accountable care. It provides approximately 250 skilled nursing centers and senior living communities in 22 states nationwide. Its... see more

Recent & Breaking News (GREY:GENN)

Genmab 2014 Annual Report

GlobeNewswire March 2, 2015

Genmab Announces That Agreement to Transfer Ofatumumab Collaboration to Novartis is Now Effective

GlobeNewswire March 2, 2015

Genesis Healthcare Reports Fiscal Year End 2014 Results

PR Newswire February 19, 2015

Genmab Enters Commercial DuoBody Technology Agreement with BioNovion in the Field of Immuno-Oncology

GlobeNewswire February 19, 2015

Genesis Healthcare To Release Year End And Fourth Quarter 2014 Results On February 19, 2015

PR Newswire February 16, 2015

Major Shareholder Announcement

GlobeNewswire February 4, 2015

Fourth Quarter and Full Year 2014 Net Sales Figures for Arzerra (ofatumumab)

GlobeNewswire February 4, 2015

Genmab Announces Preliminary Results in Phase II Study of Daratumumab in Double Refractory Multiple Myeloma

GlobeNewswire February 3, 2015

Genesis Healthcare Combines With Skilled Healthcare Group, Inc.

PR Newswire February 2, 2015

Genmab to Receive $3 Million Milestone Payment in DuoBody Platform Collaboration with Janssen

GlobeNewswire December 12, 2014

Genmab Announces Phase II Study of Daratumumab in Non-Hodgkin's Lymphomas

GlobeNewswire December 4, 2014

Genmab Announces Phase II Study of Daratumumab in Smoldering Multiple Myeloma

GlobeNewswire November 24, 2014

Genmab Announces New Phase III Combination Study of Daratumumab in Frontline Multiple Myeloma

GlobeNewswire November 10, 2014

Genmab Announces Daratumumab and Ofatumumab Data to Be Presented at American Society of Hematology Annual Meeting (ASH)

GlobeNewswire November 6, 2014

Genmab Announces Additional Data from Phase III Study of Ofatumumab as Maintenance Therapy for Relapsed CLL

GlobeNewswire November 6, 2014

Genmab Announces Financial Results for the First Nine Months of 2014

GlobeNewswire November 5, 2014

Genmab Announces Conditional Transfer of Ofatumumab Agreement

GlobeNewswire November 3, 2014

Genmab Reaches USD 10 Million Milestone in Daratumumab Collaboration with Janssen

GlobeNewswire October 23, 2014

Third Quarter 2014 Net Sales Figures for Arzerra(r)

GlobeNewswire October 22, 2014

Seattle Genetics and Genmab Enter Into New Antibody-Drug Conjugate Collaboration

GlobeNewswire September 10, 2014